[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352606-105":59,"doc-detail-352606-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-and-evaluation-of-tumor-pyroptosis-associated-antigens-for-design-a-vaccine-candidate-against-lung-cancer","Identification and evaluation of tumor pyroptosis-associated antigens for design a vaccine candidate against lung cancer","","Lung cancer remains the leading cause of cancer mortality, driving the need for innovative therapies. This study applies immunoinformatics and structural bioinformatics to design and evaluate a multi-epitope vaccine targeting pyroptosis-associated antigens (CARD8, NAIP, NLRP1, NLRP3) implicated in lung cancer immunology. Fifteen T- and B-cell epitopes are assessed for antigenicity, safety, and immune-stimulation, optimized with suitable adjuvants/linkers, and validated through antigen-physicochemical, 3D modeling, docking, and molecular dynamics analyses. In silico immune simulations indicate strong immunogenicity and efficient expression after codon optimization and cloning.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-and-evaluation-of-tumor-pyroptosis-associated-antigens-for-design-a-vaccine-candidate-against-lung-cancer/352606/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-and-evaluation-of-tumor-pyroptosis-associated-antigens-for-design-a-vaccine-candidate-against-lung-cancer/352606.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which pyroptosis-associated antigens are targeted in the multi-epitope vaccine design?","Question",{"text":112,"@type":113},"The study targets CARD8, NAIP, NLRP1, and NLRP3, which are described as implicated in lung cancer immunology.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are the selected epitopes evaluated before vaccine construction?",{"text":117,"@type":113},"The work identifies fifteen T-cell and B-cell epitopes and analyzes them for antigenicity, non-toxicity, non-allergenicity, and immune-stimulatory potential, then optimizes them for a vaccine format.",{"name":119,"@type":110,"acceptedAnswer":120},"What computational evidence supports the vaccine’s potential to activate immunity?",{"text":121,"@type":113},"Molecular docking shows stable, strong interactions with multiple immune receptors, and molecular dynamics simulations confirm structural stability and solvent accessibility over 100 ns. Immune simulations further indicate strong immunogenic responses including antibody titers, memory cell populations, and cytokine production.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352606,1790255822,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification and evaluation of tumor pyroptosis-associated antigens for design a vaccine candidate against lung cancer  \nTruc Ly Nguyen1 & Heebal Kim1,2,3􀀍  \nLung cancer is the leading cause of cancer-related mortality worldwide, emphasizing the need for innovative therapeutic strategies. This study utilized immunoinformatics and structural bioinformatics approaches to design and evaluate a multi-epitope vaccine targeting pyroptosis-associated antigens (CARD8, NAIP, NLRP1, and NLRP3), which are implicated in lung cancer immunology. Fifteen T-cell and B-cell epitopes were identified, analyzed for their antigenicity, non-toxicity, non-allergenicity, and immune-stimulatory potential, and optimized to construct a vaccine with suitable adjuvants and linkers. The vaccine demonstrated high antigenicity, solubility, and stability, as validated through physicochemical analyses. Its three-dimensional structure was modeled, refined, and validated using molecular modeling approaches. Molecular docking studies revealed stable and strong interactions between the vaccine and key immune receptors (TLR2, TLR4, TLR5, TLR3, TLR7, and TLR8), indicating its potential to activate both innate and adaptive immunity. Molecular dynamics simulations confirmed the vaccine’s structural stability and solvent accessibility over 100 ns across ten replicas. Immune simulations demonstrated strong immunogenic responses, including elevated antibody titers, memory cell populations, and cytokine production. Codon optimization and in silico cloning further ensured efficient expression in Escherichia coli, facilitating experimental application. These findings underscore the vaccine’s promise as a therapeutic candidate against lung cancer, warranting further in vitro and in vivo investigations.  \nKeywords Lung cancer, Multi-epitope vaccine, Pyroptosis-associated antigens, Immunoinformatics, Computational vaccine design, Molecular dynamics simulation  \nLung cancer is one of the most prevalent and lethal cancers worldwide, originating in the tissues of the lungs, typically within the cells lining the air passages. It is broadly classified into two main types: non-small cell lung cancer (NSCLC), which accounts for about 85% of all cases, and small cell lung cancer (SCLC)1. According to the World Health Organization (WHO), lung cancer is the leading cause of cancer-related deaths globally, responsible for approximately 1.8 million deaths annually. In 2022, GLOBOCAN estimated that lung cancer was the most commonly diagnosed cancer, with nearly 2.5 million new cases, representing one in every eight cancer diagnoses globally2. In the United States alone, the American Cancer Society estimates that in 2024, there will be about 234,580 new cases of lung cancer and around 125,070 deaths3. These alarming statistics underscore the urgent need for effective prevention, early detection, and treatment strategies. The treatment of lung cancer depends on the type, stage, and overall health of the patient, with common treatments including surgery, targeted therapy, radiation therapy, chemotherapy, and immunotherapy4.  \nVaccines play a critical role in preventing various diseases, including certain cancers. While traditional vaccines prevent infections that can lead to cancer (e.g., HPV vaccine for cervical cancer)5, cancer vaccines aim to stimulate the immune system to recognize and destroy cancer cells. Currently, no FDA-approved vaccines specifically target lung cancer, though several are under development and in clinical trials. These vaccines aim to prompt the immune system to recognize and attack lung cancer cells. For example, the Center for Molecular Immunology (CIM) in Havana, Cuba, has developed CIMAvax-EGF, a vaccine that targets the epidermal growth factor (EGF), a protein crucial for cancer cell growth6. CIMAvax-EGF works by preventing EGF from binding  \n1Department of Agricultural Biotechnolo","cbCaikwahC0AtUbK","https://ap.wps.com/l/cbCaikwahC0AtUbK","pdf",4792153,"English","# Background and need\n## Lung cancer burden and treatment landscape\n## Cancer vaccines and current status\n# Vaccine design workflow\n## Target selection: pyroptosis-associated antigens\n## Epitope identification and safety evaluation\n## Vaccine construction, adjuvants, and linkers\n# Computational validation\n## Physicochemical property analyses\n## 3D modeling, refinement, and validation\n## Molecular docking to immune receptors\n## Molecular dynamics simulations\n# Immunogenicity and expression assessment\n## Immune simulations\n## Codon optimization and in silico cloning\n# Conclusion and future work","[{\"question\":\"Which pyroptosis-associated antigens are targeted in the multi-epitope vaccine design?\",\"answer\":\"The study targets CARD8, NAIP, NLRP1, and NLRP3, which are described as implicated in lung cancer immunology.\"},{\"question\":\"How are the selected epitopes evaluated before vaccine construction?\",\"answer\":\"The work identifies fifteen T-cell and B-cell epitopes and analyzes them for antigenicity, non-toxicity, non-allergenicity, and immune-stimulatory potential, then optimizes them for a vaccine format.\"},{\"question\":\"What computational evidence supports the vaccine’s potential to activate immunity?\",\"answer\":\"Molecular docking shows stable, strong interactions with multiple immune receptors, and molecular dynamics simulations confirm structural stability and solvent accessibility over 100 ns. Immune simulations further indicate strong immunogenic responses including antibody titers, memory cell populations, and cytokine production.\"}]","Identification and evaluation of tumor pyroptosis-associated antigens for design a vaccine candidate against lung cancer | PDF",1790100441,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34e486c7f6540cac908c163b83f4fdd3.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84d466528b1e26ec8ddf4caa4d68c5cc.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/516276bef0fbb5bc81a054f22b503569.webp",981,1289,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28295940334166d21281230b5040aacd.webp",980,1287]